1. Arab, Fatemeh, Rezaei, Nima, Taheri, Forough, Zare-Abdollahi, Davood, Ghadami, Mohsen. 2022. The Clinical and Molecular Assessment of Iranian Families with Severe Congenital Neutropenia, Identification of HYOU1 and SHOC2 as Potential Novel Gene Defects. In Iranian journal of allergy, asthma, and immunology, 21, 344-354. doi:10.18502/ijaai.v21i3.9808. https://pubmed.ncbi.nlm.nih.gov/35822684/
2. Wang, Jia-Mei, Jiang, Jing-Yi, Zhang, Da-Lin, Wu, Tong, Du, Zhen-Xian. 2021. HYOU1 facilitates proliferation, invasion and glycolysis of papillary thyroid cancer via stabilizing LDHB mRNA. In Journal of cellular and molecular medicine, 25, 4814-4825. doi:10.1111/jcmm.16453. https://pubmed.ncbi.nlm.nih.gov/33792181/
3. Wang, Weiguo, Jiang, Xinjie, Xia, Fei, Zhu, Min, Chen, Cheng. 2022. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer. In Molecular biology reports, 50, 453-464. doi:10.1007/s11033-022-07978-x. https://pubmed.ncbi.nlm.nih.gov/36348197/
4. Hao, Aixin, Wang, Yu, Zhang, Xiao, Kulik, George, Sui, Guangchao. 2021. Long non-coding antisense RNA HYOU1-AS is essential to human breast cancer development through competitive binding hnRNPA1 to promote HYOU1 expression. In Biochimica et biophysica acta. Molecular cell research, 1868, 118951. doi:10.1016/j.bbamcr.2021.118951. https://pubmed.ncbi.nlm.nih.gov/33422616/
5. Wang, Ruixue, Deng, Jiaxing, Zhang, Meng, Liu, Shilong, Qi, Lishuang. 2024. Overexpression of HYOU1 is associated with cisplatin resistance and may depend on m6A modification in patients with cervical cancer. In Oncology letters, 29, 77. doi:10.3892/ol.2024.14823. https://pubmed.ncbi.nlm.nih.gov/39650230/
6. Li, X, Zhang, N-X, Ye, H-Y, Zhang, L, Wang, N-N. . HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis. In European review for medical and pharmacological sciences, 23, 4126-4135. doi:10.26355/eurrev_201901_17914. https://pubmed.ncbi.nlm.nih.gov/31173282/
7. Zhou, Shaocheng, Sheng, Lijuan, Zhang, Lin, Zhang, Jianan, Wang, Lei. 2023. METTL3/IGF2BP3-regulated m6A modification of HYOU1 confers doxorubicin resistance in breast cancer. In Biochimica et biophysica acta. General subjects, 1868, 130542. doi:10.1016/j.bbagen.2023.130542. https://pubmed.ncbi.nlm.nih.gov/38103759/
智鼠故事 
